WO2001075067A8 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides

Info

Publication number
WO2001075067A8
WO2001075067A8 PCT/US2001/008631 US0108631W WO0175067A8 WO 2001075067 A8 WO2001075067 A8 WO 2001075067A8 US 0108631 W US0108631 W US 0108631W WO 0175067 A8 WO0175067 A8 WO 0175067A8
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
polypeptides
novel nucleic
novel
present
Prior art date
Application number
PCT/US2001/008631
Other languages
French (fr)
Other versions
WO2001075067A2 (en
WO2001075067A9 (en
WO2001075067A3 (en
Inventor
Rodoje T Drmanac
Chenghua Liu
Y Tom Tang
Original Assignee
Hyseq Inc
Rodoje T Drmanac
Chenghua Liu
Y Tom Tang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc, Rodoje T Drmanac, Chenghua Liu, Y Tom Tang filed Critical Hyseq Inc
Priority to US10/450,763 priority Critical patent/US20050196754A1/en
Priority to AU2001249251A priority patent/AU2001249251A1/en
Publication of WO2001075067A2 publication Critical patent/WO2001075067A2/en
Publication of WO2001075067A3 publication Critical patent/WO2001075067A3/en
Priority to US10/128,558 priority patent/US20040219521A1/en
Priority to US10/243,552 priority patent/US20030224379A1/en
Publication of WO2001075067A9 publication Critical patent/WO2001075067A9/en
Priority to US10/302,689 priority patent/US20080050393A1/en
Publication of WO2001075067A8 publication Critical patent/WO2001075067A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The present invention provides novel nucleic acids, novel polypeptide sequences encoded by these nucleic acids and uses thereof.
PCT/US2001/008631 1998-12-03 2001-03-30 Novel nucleic acids and polypeptides WO2001075067A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US10/450,763 US20050196754A1 (en) 2000-03-31 2001-03-30 Novel nucleic acids and polypeptides
AU2001249251A AU2001249251A1 (en) 2000-03-31 2001-03-30 Novel nucleic acids and polypeptides
US10/128,558 US20040219521A1 (en) 2000-01-21 2002-04-22 Novel nucleic acids and polypeptides
US10/243,552 US20030224379A1 (en) 2000-01-21 2002-09-12 Novel nucleic acids and polypeptides
US10/302,689 US20080050393A1 (en) 1998-12-03 2002-11-22 Novel nucleic acids and polypeptides

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54021700A 2000-03-31 2000-03-31
US09/540,217 2000-03-31
US64916700A 2000-08-23 2000-08-23
US09/649,167 2000-08-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/008656 Continuation-In-Part WO2001079449A2 (en) 1998-12-03 2001-04-16 Novel nucleic acids and polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/004941 Continuation-In-Part WO2002016439A2 (en) 1998-12-03 2001-03-05 Novel nucleic acids and polypeptides

Publications (4)

Publication Number Publication Date
WO2001075067A2 WO2001075067A2 (en) 2001-10-11
WO2001075067A3 WO2001075067A3 (en) 2002-04-04
WO2001075067A9 WO2001075067A9 (en) 2002-10-31
WO2001075067A8 true WO2001075067A8 (en) 2004-10-14

Family

ID=27066367

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/008631 WO2001075067A2 (en) 1998-12-03 2001-03-30 Novel nucleic acids and polypeptides

Country Status (3)

Country Link
US (7) US6436703B1 (en)
AU (1) AU2001249251A1 (en)
WO (1) WO2001075067A2 (en)

Families Citing this family (566)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972697A (en) 1995-11-13 1999-10-26 The Salk Institute For Biological Studies NIMA interacting proteins
US7125677B2 (en) 1995-11-13 2006-10-24 The Salk Institute For Biological Studies NIMA interacting proteins
US7351421B2 (en) * 1996-11-05 2008-04-01 Hsing-Wen Sung Drug-eluting stent having collagen drug carrier chemically treated with genipin
US20050163818A1 (en) * 1996-11-05 2005-07-28 Hsing-Wen Sung Drug-eluting device chemically treated with genipin
JP2001512306A (en) 1997-01-08 2001-08-21 ライフ テクノロジーズ，インコーポレイテッド Methods for producing proteins
US20030082540A1 (en) * 1997-09-17 2003-05-01 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7417126B2 (en) * 1997-10-17 2008-08-26 Genentech, Inc. PRO246 antibodies
JP2002504331A (en) * 1998-02-19 2002-02-12 スミスクライン ビーチャム コーポレーション G protein-coupled receptor AmMaid
US6696247B2 (en) 1998-03-18 2004-02-24 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6960570B2 (en) 1998-03-18 2005-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
EP1086223B1 (en) 1998-06-01 2009-07-29 Agensys, Inc. Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US7339033B2 (en) * 1998-06-26 2008-03-04 Genentech, Inc. Pro1481
US7091315B1 (en) 1998-07-15 2006-08-15 Human Genome Sciences, Inc. Protein HDPBQ71
US20070072248A1 (en) * 1998-10-13 2007-03-29 Arena Pharmaceuticals, Inc. Constitutively activated human G protein coupled receptors
US20030229216A1 (en) * 1998-10-13 2003-12-11 Ruoping Chen Constitutively activated human G protein coupled receptors
US20080213778A1 (en) 1998-12-30 2008-09-04 Millennium Pharmaceuticals, Inc. Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
US20030190669A1 (en) 1998-12-30 2003-10-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7041474B2 (en) 1998-12-30 2006-05-09 Millennium Pharmaceuticals, Inc. Nucleic acid encoding human tango 509
US7235642B1 (en) * 1999-01-12 2007-06-26 Genentech, Inc. Anti-PRO 1313 antibodies
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US6649342B1 (en) 1999-03-15 2003-11-18 Eos Biotechnology, Inc. Methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
US6943235B1 (en) 1999-04-12 2005-09-13 Agensys, Inc. Transmembrane protein expressed in prostate cancer
AU6394400A (en) * 1999-07-30 2001-02-19 Millennium Pharmaceuticals, Inc. Secreted proteins and uses thereof
EP1218411A4 (en) * 1999-09-20 2004-09-01 Millennium Pharm Inc Secreted proteins and uses thereof
US20030228640A1 (en) * 1999-10-15 2003-12-11 University Of Pittsburgh Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
CA2490853A1 (en) * 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2003515325A (en) * 1999-12-01 2003-05-07 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド Four disulfide core domain containing (FDCD) polynucleotides, polypeptides, and antibodies
ES2360155T3 (en) 2000-01-26 2011-06-01 Agensys, Inc. 84P2A9: A SPECIFIC PROTEIN OF PROSTATE AND TESTICLES HIGHLY EXPRESSED IN PROSTATE CANCER.
AU2001236658A1 (en) * 2000-02-03 2001-08-14 Nuvelo, Inc. Methods and materials relating to neurotrimin-like polypeptides and polynucleotides
US6806254B2 (en) * 2000-02-03 2004-10-19 Nuvelo, Inc. Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
US7700341B2 (en) 2000-02-03 2010-04-20 Dendreon Corporation Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
AU2001241446A1 (en) * 2000-02-03 2001-08-14 Lexicon Genetics Incorporated Human transporter proteins and polynucleotides encoding the same
WO2002026803A2 (en) * 2000-09-25 2002-04-04 Millenium Pharmaceuticals, Inc. 22108 and 47916, novel human thioredoxin family members and uses thereof
PT1276867E (en) * 2000-03-22 2006-12-29 Bayer Healthcare Ag Use of human latrophilin-like g protein-coupled receptor in screening methods
WO2001075075A2 (en) * 2000-03-27 2001-10-11 Bayer Aktiengesellschaft Human tyrosine phosphatase-like enzymes
AU5521401A (en) * 2000-03-31 2001-10-15 Hyseq Inc Method and materials relating to insulin-like growth factor binding protein-likepolypeptides and polynucleotides
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
EP1268762A4 (en) * 2000-03-31 2003-08-27 Nuvelo Inc Novel nucleic acids and polypeptides
GB0008305D0 (en) * 2000-04-06 2000-05-24 Neutec Pharma Plc Treatment of fungal infections
JP2003530873A (en) * 2000-04-19 2003-10-21 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング NK-2 homeobox transcription regulator
US7371388B1 (en) 2000-05-04 2008-05-13 Human Genome Sciences, Inc. Treatment of Sjogren's syndrome by administration of TR18 polypeptides
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1395655A2 (en) 2000-06-06 2004-03-10 Millennium Pharmaceuticals, Inc. 52906, 33408, and 12189, potassium channel family members and uses thereof
WO2001094614A2 (en) * 2000-06-07 2001-12-13 Cyclacel Limited Methods for monitoring enzyme activity
EP1309676A2 (en) * 2000-06-12 2003-05-14 Bayer Aktiengesellschaft Human epithin-like serine protease
EP1293510A4 (en) * 2000-06-22 2005-02-09 Takeda Pharmaceutical Novel polypeptide and its dna
PT1297006E (en) 2000-06-23 2006-05-31 Bayer Healthcare Ag REGULATION OF SERENIAL PROTEASE SIMILAR TO HUMAN PROSTASIN
AU2001272493A1 (en) * 2000-06-26 2002-01-08 Merck Patent G.M.B.H Receptor for phosphoinositides-1 associated scaffold protein
DK1325115T3 (en) * 2000-06-26 2016-11-21 Zymogenetics Inc CYTOKINRECEPTOR ZCYTOR17
EP1294882A2 (en) * 2000-06-28 2003-03-26 Amgen, Inc. B7-like molecules and uses thereof
US7355023B2 (en) * 2000-06-29 2008-04-08 Duke University Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same
US20020064821A1 (en) * 2000-07-05 2002-05-30 Merkulov Gennady V. Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
US20030171324A1 (en) * 2000-07-18 2003-09-11 Shyam Ramakrishnan Regulation of human desc1-like serine protease
AU2001278488A1 (en) * 2000-07-25 2002-02-05 Bayer Aktiengesellschaft Regulation of human matriptase-like serine protease
US7402660B2 (en) 2000-08-02 2008-07-22 The Johns Hopkins University Endothelial cell expression patterns
US6924364B2 (en) 2000-08-04 2005-08-02 Zymogenetics, Inc. Human secreted protein, Zzp1
WO2002012469A2 (en) * 2000-08-09 2002-02-14 Millennium Pharmaceuticals, Inc. A human adenylate kinase family member and uses therefor
DK1313766T3 (en) * 2000-08-21 2008-10-27 Organon Nv Coaster, a human coactivator for steroid receptors
ATE328899T1 (en) 2000-09-22 2006-06-15 Kyowa Hakko Kogyo Kk CELL NUCLEAR LOCALIZING PROTEIN FOR BETA-CATENIN
AU2002210514A1 (en) * 2000-09-27 2002-04-08 Bayer Aktiengesellschaft Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
WO2002029058A2 (en) * 2000-10-05 2002-04-11 Curagen Corporation Human proteins, polynucleotides encoding them and methods of using the same
WO2002029049A2 (en) * 2000-10-05 2002-04-11 Bayer Aktiengesellschaft Regulation of human sodium-dependent monoamine transporter
US20030124704A1 (en) * 2000-10-06 2003-07-03 Strittmatter Stephen M. Nogo receptor homologs
WO2002030974A2 (en) * 2000-10-12 2002-04-18 Curagen Corporation Proteins and nucleic acids encoding same
EP1326979A2 (en) * 2000-10-18 2003-07-16 ZymoGenetics, Inc. Human cyclic nucleotide binding protein
JP4460829B2 (en) * 2000-10-20 2010-05-12 コモ・バイオテック・アンパルトセルスカブ Pregnancy-related plasma protein-A2 (PAPP-A2)
US20030068624A1 (en) * 2000-10-26 2003-04-10 Recipon Herve E. Compositions and methods relating to lung specific genes and proteins
AU2002243444A1 (en) 2000-10-31 2002-06-24 Diadexus, Inc. Compositions and methods relating to colon specific genes and proteins
WO2002050278A2 (en) * 2000-11-15 2002-06-27 Lexicon Genetics Incorporated Novel human secreted proteins and polynucleotides encoding the same
ES2349114T3 (en) * 2000-11-22 2010-12-28 University Of Maryland, Baltimore USE OF CLYA HEMOLISIN FOR THE EXCRETION OF FUSION PROTEINS.
AU2002233201A1 (en) * 2000-11-27 2002-06-03 Bayer Aktiengesellschaft Regulation of human tyrosine phosphatase
US20020081653A1 (en) * 2000-11-28 2002-06-27 Chunhua Yan Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002046477A2 (en) * 2000-12-07 2002-06-13 Chiron Corporation Endogenous retroviruses up-regulated in prostate cancer
CA2431007A1 (en) 2000-12-11 2002-07-18 Lexicon Genetics Incorporated Novel human kinase and polynucleotides encoding the same
DE10061931A1 (en) * 2000-12-13 2001-09-06 Marianne Kroepelin A new nucleic acid encoding M73791 HUMNOVGENE also known as HUMQM and human RPL10 is involved in tumor suppression and useful to diagnose and treat cancer
WO2002057460A2 (en) 2000-12-20 2002-07-25 Bristol-Myers Squibb Company Polynucleotides encoding human phosphatases
US6949363B2 (en) 2000-12-22 2005-09-27 Brilstol-Myers Squibb Polynucleotides encoding novel human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1
US7247705B2 (en) * 2000-12-28 2007-07-24 Takeda Pharmaceutical Company Limited Proteins having glucose transporter activity
WO2002053748A1 (en) * 2001-01-02 2002-07-11 Bayer Aktiengesellschaft Regulation of human 3-ss-hydroxysteroid dehydrogenase-isomerase
GB0100750D0 (en) * 2001-01-11 2001-02-21 Inpharmatica Ltd Novel proteins
US6605710B2 (en) * 2001-01-11 2003-08-12 Board Of Trustees Of Michigan State University Gene whose expression promotes differentiation of myeloid progenitor cells into neutrophils and/or monocytes/macrophages
WO2002079473A2 (en) * 2001-01-12 2002-10-10 Incyte Genomics, Inc. Molecules for diagnostics and therapeutics
EP1490509A4 (en) * 2001-01-12 2005-06-01 Exelixis Inc Modulating insulin receptor signaling
GB2375110A (en) * 2001-01-30 2002-11-06 Aeomica Inc Human LCCL_domain containing peptides
WO2002061049A2 (en) * 2001-01-31 2002-08-08 Millennium Pharmaceuticals, Inc. Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
US7041643B2 (en) 2001-01-31 2006-05-09 Millennium Pharmaceuticals, Inc. Molecules of the PYRIN/NBS/LRR protein family and uses thereof
AU2002229440A1 (en) * 2001-02-02 2002-08-19 Mount Sinai Hospital Human acid phosphatase gene
US20030166041A1 (en) * 2001-02-08 2003-09-04 Hillman Jennifer L. TIMM8b-related protein
US7601825B2 (en) 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
US20060035237A1 (en) 2002-08-26 2006-02-16 Markowitz Sanford D Methods and compositions for categorizing patients
US7081516B2 (en) 2002-08-26 2006-07-25 Case Western Reserve University Methods for categorizing patients
US7118912B2 (en) * 2002-08-26 2006-10-10 Case Western Reserve University Methods and compositions for categorizing patients
CA2439693A1 (en) * 2001-03-05 2002-10-31 Aventis Pharma S.A. Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
US6924358B2 (en) 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
MXPA03008039A (en) 2001-03-08 2004-05-24 Immunex Corp Human serpin polypeptides.
US8647826B2 (en) 2001-03-14 2014-02-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
AU2002250143A1 (en) * 2001-03-16 2002-10-03 Eli Lilly And Company Lp mammalian proteins; related reagents
US6551809B2 (en) * 2001-03-20 2003-04-22 Applera Corporation Isolated human phosphatase proteins, nucleic acid molecules encoding human phophatase proteins, and uses thereof
JP4590157B2 (en) 2001-03-21 2010-12-01 アイシス イノヴェイション リミテッド Assays, methods and means
US20040209264A1 (en) * 2001-03-23 2004-10-21 Thomas Kramps New essential downstream component of the wingless signalling pathway
JP2004529639A (en) * 2001-03-23 2004-09-30 バイエル アクチェンゲゼルシャフト Regulation of human bispecific protein phosphatase 7-like protein
NZ527971A (en) * 2001-03-27 2006-03-31 Dendreon Corp Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
WO2002081515A1 (en) * 2001-04-03 2002-10-17 Kyowa Hakko Kogyo Co., Ltd. Insulin-like growth factor-binding protein
WO2002088303A2 (en) 2001-04-03 2002-11-07 Bristol-Myers Squibb Company Polynucleotide encoding a novel cysteine protease of the calpain superfamily, can-12, and variants thereof
AU2002258626B2 (en) 2001-04-10 2007-01-18 Agensys, Inc. Nucleid acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
WO2002083921A2 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
AU2002303340A1 (en) 2001-04-10 2002-10-28 Agensys, Inc. Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
US20030191073A1 (en) 2001-11-07 2003-10-09 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
WO2002083866A2 (en) * 2001-04-17 2002-10-24 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
US7309760B2 (en) * 2001-04-17 2007-12-18 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
CA2444504A1 (en) * 2001-04-26 2002-11-07 Pe Corporation (Ny) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
US7713526B2 (en) 2001-05-01 2010-05-11 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
AU2002308557A1 (en) 2001-05-01 2002-11-11 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
JP2004535794A (en) 2001-05-03 2004-12-02 チルドレンズ・メディカル・センター・コーポレイション Sperm-specific cation channels and uses thereof
US7217785B2 (en) * 2001-05-09 2007-05-15 The Regents Of The University Of California Cysteine-containing peptides having antioxidant properties
US20040152092A1 (en) * 2001-05-11 2004-08-05 Alex Smolyar Regulation of human phosphatidic acid phosphatase type 2c-like protein
US7304034B2 (en) 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
US7220723B2 (en) 2001-05-15 2007-05-22 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
CN100447154C (en) * 2001-05-15 2008-12-31 费因斯坦医学研究学院 Use of HMG fragments as anti-inflammatory agents
WO2002095002A2 (en) * 2001-05-22 2002-11-28 University Of Chicago N4 virion single-stranded dna dependent rna polymerase
WO2002099134A1 (en) * 2001-06-05 2002-12-12 Auckland Uniservices Limited Methods and compositions for assessment of pulmonary function and disorders
WO2002098889A2 (en) * 2001-06-05 2002-12-12 Exelixis Inc. MAP3Ks AS MODIFIER OF THE p53 PATHWAY AND METHODS OF USE
WO2003008450A1 (en) * 2001-06-12 2003-01-30 Kyogo Itoh Tumor antigen
EP1266906A1 (en) * 2001-06-13 2002-12-18 Millennium Pharmaceuticals, Inc. 46584, a human transporter family member and uses therefor
JP2004531268A (en) * 2001-06-14 2004-10-14 レキシコン・ジェネティクス・インコーポレーテッド Novel human transporter protein and polynucleotide encoding the same
US20030143668A1 (en) * 2001-06-18 2003-07-31 National Institute Of Advanced Industrial Guanosine triphosphate-binding protein coupled receptors
US20030120040A1 (en) 2001-06-29 2003-06-26 Genentech, Inc. Secreted and Transmembrane polypeptides and nucleic acids encoding the same
ITMI20011465A1 (en) * 2001-07-10 2003-01-10 Novuspharma Spa GENE WITH ONCOSUPPRESSIVE ACTIVITY
WO2003006688A2 (en) * 2001-07-13 2003-01-23 University Of Aarhus Methods for diagnosis and treatment of diseases associated with altered expression of gnas
JP2003024080A (en) * 2001-07-19 2003-01-28 Univ Tokyo Protein inducing p53-dependent apoptosis and method for screening apoptosis controlling agent
US20040210042A1 (en) * 2001-07-19 2004-10-21 Tsuchida Jun-Ichi Polypeptides relating to signal transfer of advanced glycation end product receptor
WO2003010198A1 (en) * 2001-07-26 2003-02-06 Kenton Srl Identification of specific tumour antigens by selection of cdna libraries with sera and use of said antigens in diagnostic techniques
WO2003012038A2 (en) 2001-07-27 2003-02-13 Wyeth Aggrecanase molecules
WO2003024389A2 (en) 2001-07-30 2003-03-27 Immunex Corporation T. reesei phytase enyzmes, polynucleides encoding the enzymes, vectors and host cells thereof, and methods of using
FR2828209A1 (en) * 2001-08-01 2003-02-07 Cytomics Systems New nucleic acid encoding HECT-domain polypeptides, useful e.g. for treatment of cancer or inflammation, also new proteins, antibodies and modulators
JP2003135063A (en) * 2001-08-24 2003-05-13 Chiba Prefecture New gene nedl-1
EP1757693A3 (en) * 2001-08-24 2007-05-09 Hisamitsu Pharmaceutical Co. Inc. Nucleic acids showing difference in expression between hepatoblastoma and normal liver
IL160651A0 (en) 2001-08-31 2004-07-25 Agensys Inc Nucleic acid and correspondidng protein entitled 205pib5 and pharmaceutical compositions containing the same
ES2537074T3 (en) 2001-09-06 2015-06-02 Agensys, Inc. Nucleic acid and corresponding protein called STEAP-1 useful in the treatment and detection of cancer
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
EP2339029B1 (en) * 2001-09-14 2016-03-09 Clinical Genomics Pty. Ltd Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
WO2003099318A2 (en) * 2002-05-29 2003-12-04 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Pancreas-specific proteins
US20050222070A1 (en) 2002-05-29 2005-10-06 Develogen Aktiengesellschaft Fuer Entwicklungsbiologische Forschung Pancreas-specific proteins
AU2002326957B2 (en) * 2001-09-19 2006-08-10 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Transductin-1 and transductin-2 and applications to hereditary deafness
JP2003093056A (en) * 2001-09-26 2003-04-02 Japan Science & Technology Corp ENZYME PHOSPHORYLATING Ser46 of p53
US20030108928A1 (en) * 2001-10-09 2003-06-12 Millennium Pharmaceuticals, Inc. MID 241 receptor, a novel G-protein coupled receptor
CA2463578A1 (en) * 2001-10-16 2003-04-24 Autogen Research Pty Ltd Differentially expressed genes associated with obesity and type 2 diabetes
US20030100034A1 (en) * 2001-10-16 2003-05-29 Millennium Pharmaceuticals, Inc. 9136, a human aldehyde dehydrogenase family member and uses therefor
DE10152598A1 (en) * 2001-10-19 2003-05-22 Schering Ag ARL-2-for fertility control
US8729248B2 (en) 2001-10-22 2014-05-20 Children's Medical Center Corporation Sperm-specific cation channel, CATSPER2, and uses therefor
AU2002364939A1 (en) 2001-10-22 2003-07-09 Board Of Regents, The University Of Texas System Sperm-specific cation channel, catsper2, and uses therefor
DE10153259A1 (en) * 2001-10-31 2003-05-22 Osram Opto Semiconductors Gmbh Optoelectronic component
AU2002359331A1 (en) * 2001-10-31 2003-06-10 Millennium Pharmaceuticals, Inc. Methods and compositions for the treatment and diagnosis of cellular proliferative disorders using 32222
EP1446507A2 (en) * 2001-10-31 2004-08-18 Pfizer Products Inc. Therapeutics and diagnostics for disorders of erythropoiesis
IL161268A0 (en) 2001-11-07 2004-09-27 Agensys Inc Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same
EP1442118A2 (en) * 2001-11-08 2004-08-04 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
WO2003042370A2 (en) * 2001-11-14 2003-05-22 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services New gene expressed in prostate cancer and methods of use
US7074576B2 (en) * 2001-11-23 2006-07-11 Syn X Pharma, Inc. Protein biopolymer markers indicative of alzheimer's disease
US20030100016A1 (en) * 2001-11-23 2003-05-29 George Jackowski Complement C3 precursor biopolymer markers predictive of Alzheimers disease
CA2468326C (en) * 2001-11-26 2015-11-17 Pierre Legrain Protein-protein interactions in human immunodeficiency virus
WO2003046165A1 (en) * 2001-11-26 2003-06-05 Bayer Healthcare Ag Regulation of human aldose reductase-like protein
AU2002360460A1 (en) * 2001-12-03 2003-06-17 Nuvelo, Inc. Methods and materials relating to novel polypeptides and polynucleotides
EP1318406B1 (en) * 2001-12-04 2005-11-09 B.R.A.H.M.S Aktiengesellschaft Use of Glycine-N-Acyl-Transferase (GNAT) for diagnosis of inflammatory diseases and sepsis
US20060275747A1 (en) * 2001-12-07 2006-12-07 Hardy Stephen F Endogenous retrovirus up-regulated in prostate cancer
AU2002351332A1 (en) * 2001-12-07 2003-06-23 Chiron Corporation Endogenous retrovirus polypeptides linked to oncogenic transformation
GB2398786A (en) * 2001-12-10 2004-09-01 Amersham Plc Human prostate cancer candidate protein 1
WO2003052119A2 (en) * 2001-12-14 2003-06-26 Incyte Genomics, Inc. Transporters and ion channels
AU2002357850A1 (en) * 2001-12-14 2003-06-30 Incyte Genomics, Inc. Neurotransmission-associated proteins
ES2337989T3 (en) * 2001-12-18 2010-05-03 Endocube Sas NEW PROTEINS ASSOCIATED WITH THE DEATH OF THE THAP FAMILY AND RELATED PAR4 ROUTES INVOLVED IN THE CONTROL OF APOPTOSIS.
US7858297B2 (en) * 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
JP3837524B2 (en) 2001-12-19 2006-10-25 国立大学法人 長崎大学 Nucleic acid, probe comprising the nucleic acid, and screening method using the probe
JP2003245084A (en) 2001-12-20 2003-09-02 Morinaga Milk Ind Co Ltd New gene useful for diagnosis and treatment of aplasia of corpus callosum and aspermatogenesis and use thereof
US20050112618A1 (en) * 2001-12-21 2005-05-26 Fagan Richard J. Secreted protein
GB0130720D0 (en) * 2001-12-21 2002-02-06 Serono Internat S A Proteins
WO2003059938A1 (en) * 2001-12-21 2003-07-24 Ramot At Tel Aviv University Ltd. Chromatin remodeling protein as a marker expressed by stromal progenitor cells
WO2003060129A1 (en) * 2002-01-16 2003-07-24 Bayer Healthcare Ag Regulation of human fatty acid coa ligase-like amp-binding enzyme
WO2003060110A2 (en) * 2002-01-16 2003-07-24 Bayer Healthcare Ag Regulation of human fatty acid coa ligase-like amp-binding enzyme
US20060088828A1 (en) * 2002-01-23 2006-04-27 Harris Peter C Polycystic kidney disease nucleic acids and proteins
WO2003062429A1 (en) * 2002-01-23 2003-07-31 Yamanouchi Pharmaceutical Co., Ltd. Novel serine protease
GB0202149D0 (en) * 2002-01-30 2002-03-20 Univ Edinburgh Pluripotency determining factors and uses thereof
EP1474515A2 (en) * 2002-02-01 2004-11-10 Bayer HealthCare AG Regulation of human hematopoietin receptor-like protein
EP1485406A4 (en) * 2002-02-20 2006-02-01 Invitrogen Corp Highly homogeneous molecular markers for electrophoresis
EP1338606A1 (en) * 2002-02-22 2003-08-27 Magnus Von Knebel Doeberitz Nucleic Acid encoding an HERV-H polypeptide for diagnosing colorectal cancer
GB2388113A (en) * 2002-03-06 2003-11-05 Oxford Glycosciences B-cell malignancy-associated protein
JP2003259872A (en) * 2002-03-07 2003-09-16 Japan Science & Technology Corp Human esophageal carcinoma antigenic peptide and method for diagnosing esophageal carcinoma
JPWO2003074701A1 (en) * 2002-03-07 2005-06-30 株式会社 ビーエフ研究所 p18AβrP gene and p18AβrP protein, a novel gene / protein (p60TRP) that interacts with these to suppress cell death, and a substance that promotes cell death
IL163733A0 (en) 2002-03-08 2005-12-18 Eisai Co Ltd Presynaptic protein p120
DE10211088A1 (en) * 2002-03-13 2003-09-25 Ugur Sahin Gene products differentially expressed in tumors and their use
AU2012216265B2 (en) * 2002-03-13 2015-01-22 Biontech Ag Genetic products differentially expressed in tumors and use thereof
EP1491630B1 (en) * 2002-03-14 2009-11-11 National Institute of Advanced Industrial Science and Technology N-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor
WO2003083078A2 (en) 2002-03-28 2003-10-09 Bristol-Myers Squibb Company Novel human cell surface protein with immunoglobulin folds, bgs-19
US20040002593A1 (en) * 2002-04-04 2004-01-01 Reed John C. PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use
AU2003222189A1 (en) * 2002-04-05 2003-10-27 Incyte Corporation Secreted proteins
AU2003222965A1 (en) * 2002-04-05 2003-10-27 University Court Of The University Of Edinburgh Schizophrenia associated genes
US7544767B2 (en) * 2002-04-05 2009-06-09 Burnham Institute For Medical Research HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
EP1576099A4 (en) 2002-04-12 2007-07-11 Bristol Myers Squibb Co Novel polynucleotides encoding the human citron kinase polypeptide, bmsnkc 0020/0021
US7459424B2 (en) 2002-04-22 2008-12-02 The Borad Of Trustees Of The Leland Stanford Junior University Peptide inhibitors of protein kinase C γ for pain management
EP1576096A4 (en) * 2002-04-23 2007-05-23 Univ Georgia Res Found N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS
US20060160728A1 (en) * 2002-04-26 2006-07-20 Heinz Von Der Kammer Diagnostic and therapeutic use of ensandin-0138 gene and protein for neurodegenerative diseases
AU2003301984A1 (en) * 2002-05-15 2004-06-03 Incyte Corporation Vesicle-associated proteins
ATE414789T1 (en) * 2002-05-21 2008-12-15 Mtm Lab Ag MARKER FOR LUNG TUMORS
US7339028B2 (en) * 2002-06-06 2008-03-04 The Trustees Of Columbia University In The City Of New York Mahoganoid polypeptides, and related compositions and methods
SG145559A1 (en) 2002-06-06 2008-09-29 Oncotherapy Science Inc Genes and polypeptides relating to human colon cancers
JP2005528913A (en) * 2002-06-10 2005-09-29 メルク　エンド　カムパニー　インコーポレーテッド Isolated nucleic acid molecules encoding novel centromere-related motor proteins and uses thereof
AU2003276679A1 (en) * 2002-06-13 2003-12-31 Chiron Corporation Vectors for expression of hml-2 polypeptides
AU2003238032A1 (en) * 2002-06-24 2004-01-06 Bayer Healthcare Ag Regulation of human growth hormone-releasing hormone receptor
FR2841261B1 (en) * 2002-06-25 2004-08-27 Univ Pasteur COMPOSITIONS AND METHODS FOR DETECTING PATHOLOGIES AFFECTING NEUROMUSCULAR TRANSMISSION
WO2004001017A2 (en) * 2002-06-25 2003-12-31 Tao Biosciences, Llc Methods for identifying antimicrobial agents, the agents identified therewith and methods of using same
AU2003251008A1 (en) * 2002-07-09 2004-01-23 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Diagnostic tests for the detection of peripheral neuropathy
AU2003253930A1 (en) * 2002-07-11 2004-02-02 Seattle Genetics, Inc. Sga-72m, a cancer associated antigen, and uses thereof
CA2493061A1 (en) 2002-07-16 2004-01-22 Guangjie Cheng Regulatory protein for nox enzymes
EP1382613A1 (en) 2002-07-16 2004-01-21 Sumitomo Chemical Company, Limited Novel G protein, polynucleotide encoding the same and utilization thereof
GB0216661D0 (en) * 2002-07-17 2002-08-28 Ares Trading Sa Protein
US7135556B2 (en) 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
US20040132058A1 (en) * 2002-07-19 2004-07-08 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
US20050163821A1 (en) * 2002-08-02 2005-07-28 Hsing-Wen Sung Drug-eluting Biodegradable Stent and Delivery Means
US20050019404A1 (en) * 2003-06-30 2005-01-27 Hsing-Wen Sung Drug-eluting biodegradable stent
AU2003258056A1 (en) 2002-08-07 2004-02-25 Children's Medical Center Corporation Sperm-specific cation channel, catsper-3, and uses therefor
AU2003263981A1 (en) 2002-08-07 2004-02-25 Children's Medical Center Corporation Sperm-specific cation channel, catsper-4, and uses therefor
US7408048B2 (en) 2002-08-09 2008-08-05 Melbourne Health Mammalian grainyhead transcription factors
AU2003304034A1 (en) * 2002-08-09 2004-11-01 Curagen Corporation Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2004016733A2 (en) 2002-08-16 2004-02-26 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
AU2003282785A1 (en) * 2002-08-26 2004-03-11 Case Western Reserve University Methods for treating patients and identifying therapeutics
DE10242146A1 (en) 2002-09-04 2004-03-18 Eberhard-Karls-Universität Tübingen Universitätsklinikum Antibodies for the identification and / or isolation of hematopoietic stem cells
EP1575497A4 (en) * 2002-09-11 2010-11-03 Genentech Inc Novel composition and methods for the treatment of psoriasis
EP1398372A1 (en) * 2002-09-13 2004-03-17 Universitätsklinikum Charité an der Humboldt- Universität zu Berlin Lipid phosphate phosphatases and uses thereof for treating neuronal diseases
WO2004024914A1 (en) * 2002-09-13 2004-03-25 Sankyo Company, Limited 2’,5’-oligoadenylate phosphodiesterase
US6892925B2 (en) * 2002-09-18 2005-05-17 International Business Machines Corporation Solder hierarchy for lead free solder joint
US20060292668A1 (en) * 2002-09-19 2006-12-28 Zhengbin Yao Nuclear factor of activated t cell receptor
JP2006500074A (en) * 2002-09-27 2006-01-05 オリディス・ビオメド・フォルシュングス−ウント・エントヴィックルングス・ゲーエムベーハー Polypeptides and nucleic acids encoding them and their use for prevention, diagnosis or treatment of liver damage and epithelial cancer
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
AU2003279829A1 (en) * 2002-10-04 2004-05-04 Incyte Corp Protein modification and maintenance molecules
EP1559725A4 (en) * 2002-10-04 2005-12-14 Mitsubishi Pharma Corp Antigen recognizing antibody
EP1575518A4 (en) 2002-10-10 2007-08-22 Wyeth Corp Compositions, organisms and methodologies employing a novel human kinase
GB0224116D0 (en) * 2002-10-16 2002-11-27 Ares Trading Sa Proteins
WO2004038411A2 (en) * 2002-10-24 2004-05-06 Evotec Neurosciences Gmbh Diagnostic and therapeutic use of ensadin-0289 gene and protein for neurodegenerative diseases
EP1554385A2 (en) * 2002-10-24 2005-07-20 Wyeth Calcineurin-like human phoshphoesterase
EP1557178A4 (en) * 2002-10-29 2009-07-22 Takeda Pharmaceutical Use of sglt homolog
US7537914B1 (en) * 2002-11-04 2009-05-26 Florida State University Research Foundation, Inc. Nucleic acid and allergenic polypeptides encoded thereby in cashew nuts (Anacardium occidentale)
WO2004044205A1 (en) * 2002-11-11 2004-05-27 Korea Chungang Educational Foundation Plant seed-specific expression promoter derived from sesame and seed-specific expression vector comprising the promoter
NZ541504A (en) * 2002-11-13 2009-04-30 Uab Research Foundation Synthetic single domain polypeptides mimicking apolipoprotein E and methods of use
US7405289B2 (en) * 2002-11-13 2008-07-29 Metabolex, Inc. Pancreatic islet transcription factor and uses thereof
WO2004048521A2 (en) * 2002-11-21 2004-06-10 Wyeth Composition and method for treating lupus nephritis
DE10254601A1 (en) * 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Gene products differentially expressed in tumors and their use
EP1572975B1 (en) 2002-11-26 2014-07-16 University Of Tennessee Research Foundation Streptococcus uberis adhesion molecule
AU2003290664A1 (en) 2002-11-27 2004-06-23 Wei Liu Compositions, organisms and methodologies employing a novel human kinase
WO2004050702A2 (en) * 2002-12-04 2004-06-17 Applied Research Systems Ars Holding N.V. Novel ifngamma-like polypeptides
US6854636B2 (en) * 2002-12-06 2005-02-15 International Business Machines Corporation Structure and method for lead free solder electronic package interconnections
US7465581B2 (en) * 2002-12-18 2008-12-16 The Scripps Research Institute ANKTM1, a cold-activated TRP-like channel expressed in nociceptive neurons
US20050049214A1 (en) * 2003-01-15 2005-03-03 Chiron Corporation Inhibition of E3-ubiquitin ligase HAKAI for treatment of proliferative disorders
US7638270B2 (en) 2003-01-24 2009-12-29 Agensys, Inc. Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer
AU2007231823B2 (en) * 2003-01-24 2011-07-21 Agensys, Inc. Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer
US7304036B2 (en) 2003-01-28 2007-12-04 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2004069174A2 (en) * 2003-01-31 2004-08-19 Slil Biomedical Corporation Monitoring and treatment of amyotrophic lateral sclerosis
US7521534B1 (en) * 2003-03-03 2009-04-21 The University Board Of Regents Of Texas System IKK gamma gene products and methods for making and using same
EP1923400A1 (en) * 2003-03-03 2008-05-21 Genentech, Inc. Compositions and methods for the treatment of systemic lupus erythematosis
US7749695B2 (en) 2003-03-03 2010-07-06 Alexander Abbas PRO polypeptides for diagnosis of systemic lupus erythematosis
CA2518552A1 (en) * 2003-03-11 2004-09-23 Genentech, Inc. Novel compositions and methods for the treatment of immune related disease
EP1608983A2 (en) * 2003-03-20 2005-12-28 Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute for Biomedical Research Materials and methods for modulating cell motility
EP1464651A1 (en) * 2003-04-03 2004-10-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Dystrophin-related protein (Drop1), a marker for carcinomas
WO2004087748A1 (en) * 2003-04-04 2004-10-14 Centre National De La Recherche Scientifique Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same
WO2004092213A1 (en) * 2003-04-08 2004-10-28 The Government Of The United States Of America As Represented By The Secretary, Department Of Healthand Human Services Gene expressed in prostate cancer, methods and use thereof
WO2004094651A2 (en) * 2003-04-18 2004-11-04 Five Prime Therapeutics, Inc. Novel human polypeptides encoded by polynucleotides
US20050032695A1 (en) * 2003-05-30 2005-02-10 Aventis Pharma Deutschland Gmbh Method for alleviating pain using protein associated with MYC and related compounds, and assays for identifying such compounds
US7696169B2 (en) 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
FR2843753A1 (en) * 2003-06-20 2004-02-27 Gene Signal Antisense nucleic molecule useful as inhibitor of angiogenesis in the treatment of angiogenic disorders, e.g., rheumatoid arthritis, atherosclerosis and endometriosis
EP1636379A2 (en) * 2003-06-26 2006-03-22 Exonhit Therapeutics S.A. Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis
FR2857098B1 (en) * 2003-07-04 2006-05-05 Inst Nat Sante Rech Med METHOD FOR THE EVIDENCE OF A MOLECULAR EVENT IN A CELL USING FLUORESCENT MARKER PROTEINS
GB0315827D0 (en) * 2003-07-05 2003-08-13 Imp College Innovations Ltd Methods
WO2005049791A2 (en) * 2003-07-14 2005-06-02 The Uab Research Foundation Identification of reagents for the diagnosis and study of francisella
EP1507004A1 (en) * 2003-08-14 2005-02-16 DKFZ Deutsches Krebsforschungszentrum Method to inhibit the propagation of an undesired cell population
WO2005019255A1 (en) 2003-08-25 2005-03-03 Pieris Proteolab Ag Muteins of tear lipocalin
WO2005024011A2 (en) * 2003-09-04 2005-03-17 Applied Research Systems Ars Holding N.V. Novel ubp8rp polypeptides and their use in the treatment of psoriasis
US8283307B2 (en) 2003-09-08 2012-10-09 Merck Serono Sa Treatment of fibrotic disease
DE10341812A1 (en) * 2003-09-10 2005-04-07 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
CA2538763C (en) 2003-09-11 2015-05-05 Critical Therapeutics, Inc. Monoclonal antibodies against hmgb1
WO2005030953A1 (en) * 2003-09-30 2005-04-07 Daiichi Pharmaceutical Co., Ltd. Tetrahydrofolate synthase gene
EP1692260A2 (en) * 2003-10-06 2006-08-23 Centocor, Inc. Hypoxia - responsive human cngh-0002 genes and polypeptides
US7985401B2 (en) 2003-10-31 2011-07-26 The Regents Of The University Of California Peptides whose uptake by cells is controllable
US7431915B2 (en) * 2003-10-31 2008-10-07 The Regents Of The University Of California Peptides whose uptake by cells is controllable
WO2005051981A1 (en) * 2003-11-19 2005-06-09 Pepharm R & D Limited Biologically active peptides comprising isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (ivtntt)
WO2005051994A2 (en) * 2003-11-21 2005-06-09 Zymogenetics, Inc. Ztnf11, a tumor necrosis factor
NZ547629A (en) * 2003-11-26 2009-08-28 Max Planck Gesellschaft Antibodies binding to conformationally discriminating epitopes of human IGG Fc receptor IIb and IIb
CA2549710A1 (en) * 2003-12-15 2005-06-23 Genesis Research And Development Corporation Limited Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them
GB0329958D0 (en) * 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
CA2553769C (en) 2004-01-16 2011-01-04 Merck & Co., Inc. Npc1l1 (npc3) and methods of identifying ligands thereof
US7785805B2 (en) 2004-01-28 2010-08-31 Exelixis, Inc. MAN2As as modifiers of the IGFR pathway and methods of use
US7148192B2 (en) * 2004-01-29 2006-12-12 Ebwe Pharma Ges. M.H. Nfg.Kg Neuroprotective dietary supplement
US20050255530A1 (en) * 2004-02-06 2005-11-17 Keefer Carol L Identification and isolation of pluripotency determining factors
GB0403142D0 (en) * 2004-02-12 2004-03-17 Ares Trading Sa Protein
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
CA2560066A1 (en) 2004-03-01 2005-09-15 The Cbr Institute For Biomedical Research, Inc. Natural igm antibodies and inhibitors thereof
US7166433B2 (en) * 2004-03-03 2007-01-23 The United States Of America As Represented By The Department Of Health And Human Services Transductin-1 and transductin-2 and applications to hereditary deafness
US20070254283A1 (en) * 2004-03-04 2007-11-01 Roy Deudutta Brhf1 as a Cancer Diagnostic Marker
US20080050315A1 (en) * 2004-03-24 2008-02-28 Stefan Golz Diagnostics and Therapeutics for Diseases Associated with Protein Kinase, Cgmp-Dependent, Type I (Prkg1)
WO2005098440A2 (en) * 2004-03-26 2005-10-20 Immusol, Inc. Methods for identifying agents useful for the treatment of neurodegenerative diseases
EP1733743A4 (en) 2004-04-09 2007-06-27 Takeda Pharmaceutical Preventives/remedies for cancer
WO2005108563A2 (en) * 2004-04-19 2005-11-17 University Of Chicago Peptidoglycan-hydrolyzing protein encoded by bacteriophage n4
BRPI0418766B8 (en) 2004-04-22 2021-05-25 Agensys Inc antibody or fragment thereof, vector, pharmaceutical composition, assay and method for detecting the presence of step-1 protein, as well as a method for delivering a cytotoxic agent or a diagnostic agent
CA2504920C (en) 2004-05-14 2014-04-01 Euroscreen S.A. Ligand for g-protein coupled receptor fprl2 and uses thereof
DE102004024617A1 (en) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
JP4649575B2 (en) * 2004-05-19 2011-03-09 財団法人ヒューマンサイエンス振興財団 Diagnosis of novel mucin genes and mucosal-related diseases
WO2005114200A1 (en) * 2004-05-21 2005-12-01 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor kinase 7 (grk7)
DK2031063T3 (en) 2004-06-18 2014-01-27 Univ Duke Modulators of fragrance receptors
CA2559760A1 (en) * 2004-07-02 2006-07-06 Metanomics Gmbh Process for the production of fine chemicals
EP2287310B1 (en) * 2004-07-22 2015-05-06 Five Prime Therapeutics, Inc. Compositions and methods using MGD-CSF in disease treatment
WO2006022689A1 (en) * 2004-08-06 2006-03-02 Applera Corporation Method and compositions for treating diseases targeting cd51
US8435507B2 (en) 2004-08-19 2013-05-07 University Of Maryland Prostate-specific antigen-derived MHC class II restricted peptides and their use in vaccines to treat or prevent prostate cancer
JP2008512120A (en) * 2004-09-08 2008-04-24 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ Cancer-testis antigen
EP2292753A1 (en) 2004-09-24 2011-03-09 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers by tRNA-dihydrouridine synthase activity of URLC8
US9944713B2 (en) * 2004-11-24 2018-04-17 Medicinal Bioconvergence Research Center Antibody specific to the AIMP2-DX2
CA2590180A1 (en) * 2004-12-10 2006-06-15 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Binding partners of antibodies specific for dendritic cell antigens
DE102004059781A1 (en) * 2004-12-10 2006-06-22 Sanofi-Aventis Deutschland Gmbh Use of serum / glucocorticoid-regulated kinase
PT1838733E (en) 2004-12-21 2011-12-13 Medimmune Ltd Antibodies directed to angiopoietin-2 and uses thereof
EP1851543A2 (en) 2005-02-24 2007-11-07 Compugen Ltd. Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
AU2006230563B8 (en) 2005-03-31 2010-06-17 Agensys, Inc. Antibodies and related molecules that bind to 161P2F10B proteins
US8350009B2 (en) 2005-03-31 2013-01-08 Agensys, Inc. Antibodies and related molecules that bind to 161P2F10B proteins
WO2006111586A2 (en) * 2005-04-20 2006-10-26 Proyecto De Biomedicina Cima, S.L. Method for the in vitro determination of the degree of methylation of the line-1 promoter
AU2006248201A1 (en) * 2005-05-19 2006-11-23 Synergenz Bioscience Limited Methods for the assesssment of risk of developing lung cancer using analysis of genetic polymorphisms
CA2608158A1 (en) * 2005-05-19 2006-11-23 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders
AU2006248189A1 (en) * 2005-05-20 2006-11-23 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
AU2006284716B2 (en) * 2005-09-01 2012-02-09 The Feinstein Institute For Medical Research Peptide mimics of melanocyte stimulating hormone
US7659252B2 (en) 2005-09-15 2010-02-09 Novomed Technologies, Inc. (Shanghai) Transdermal delivery peptides and method of use thereof
WO2007035474A2 (en) * 2005-09-15 2007-03-29 Novomed Technologies, Inc. (Shanghai) Transdermal delivery peptides and method of use thereof
WO2007053803A2 (en) * 2005-10-31 2007-05-10 Centocor, Inc. Antagonist of teb4 and methods of use
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
US20070186295A1 (en) * 2006-01-25 2007-08-09 Daniel Chelsky TAT-036 and methods of assessing and treating cancer
BRPI0706784A2 (en) * 2006-01-30 2011-04-05 Ludwig Inst Cancer Res testis cancer antigen ctsp
WO2007090194A2 (en) * 2006-02-01 2007-08-09 The Burnham Institute For Medical Research Lymphatic zip codes in tumors and pre-malignant lesions
CN107446033B (en) * 2006-02-22 2022-04-01 朱正崙 Treatment of developmental related disorders
WO2007100807A2 (en) 2006-02-24 2007-09-07 Schering Corporation Npc1l1 orthologues
WO2007104511A1 (en) * 2006-03-13 2007-09-20 Mubio Products Bv Cancer vaccine
US7811787B2 (en) * 2006-04-25 2010-10-12 Bristol-Myers Squibb Company Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3
EP2502628B1 (en) * 2006-06-23 2016-12-14 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in cancer
KR20090064378A (en) * 2006-08-10 2009-06-18 온코세라피 사이언스 가부시키가이샤 Genes and polypeptides relating breast cancers
EP2695896B1 (en) 2006-10-06 2018-08-22 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Prevention of tissue ischemia, related methods and compositions
PT2502938E (en) 2006-10-27 2015-06-05 Genentech Inc Antibodies and immunoconjugates and uses therefor
EP2052085B1 (en) * 2006-12-21 2019-05-22 Cognosci, Inc. Methods for modulating set and uses thereof
US8309687B2 (en) * 2007-03-15 2012-11-13 Reverse Proteomics Research Institute Co., Ltd. Biomarker specific for cancer
WO2008121007A1 (en) * 2007-03-29 2008-10-09 Auckland Uniservices Limited Novel saratan polypeptides and polynucleotides and methods of use thereof
WO2008126517A1 (en) * 2007-03-30 2008-10-23 National University Corporation Okayama University Novel slc17-type transporter protein in mammal and use thereof
US20100249038A1 (en) * 2007-06-12 2010-09-30 Board Of Regents, University Of Texas System Antagonists of the receptor for advanced glycation end-products (rage)
FR2919616A1 (en) * 2007-08-02 2009-02-06 Ecole Norm Superieure Lyon INSULATORY POLYNUCLEOTIDES DERIVED FROM THE D4Z4 ELEMENT AND THEIR USES IN TRANSGENESIS
US8163874B2 (en) * 2007-08-06 2012-04-24 The United States Of America, As Represented By The Secretary Of The Navy Beta helical peptide structures stable in aqueous and non-aqueous media and methods for preparing same
CN103483424A (en) * 2007-08-09 2014-01-01 诺瓦提斯公司 Thiopeptide precursor protein, gene encoding it and uses thereof
EP3492488A1 (en) 2007-08-22 2019-06-05 The Regents of The University of California Activatable binding polypeptides and methods of identification and use thereof
CA2695559A1 (en) * 2007-08-24 2009-03-05 Ramot At Tel-Aviv University, Ltd. Neuroprotection using nap-like and sal-like peptide mimetics
AU2008296478B9 (en) 2007-08-28 2015-03-19 The Uab Research Foundation Synthetic apolipoprotein E mimicking polypeptides and methods of use
DE102007041657A1 (en) * 2007-09-03 2009-03-05 Protagen Ag Marker sequences for multiple sclerosis and their use
US8450279B2 (en) * 2007-09-04 2013-05-28 Procell Therapeutics Inc. Cell permeable Nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same
EP2198306A1 (en) 2007-09-06 2010-06-23 Case Western Reserve University Methods for diagnosing and treating cancers
WO2009039188A1 (en) * 2007-09-17 2009-03-26 Ludwig Institute For Cancer Research Ltd Peptides and methods for the treatment of gliomas and other cancers
AU2008301888A1 (en) * 2007-09-20 2009-03-26 R. Bradley Jones Long interspersed nuclear element polypeptide compositions and methods of use thereof
GB0719367D0 (en) 2007-10-03 2007-11-14 Procarta Biosystems Ltd Transcription factor decoys, compositions and methods
JP2011521626A (en) * 2008-05-02 2011-07-28 エピセンター テクノロジーズ コーポレーション RNA polyphosphatase compositions, kits and uses thereof
US8324165B2 (en) 2008-05-14 2012-12-04 Five Prime Therapeutics, Inc. Compositions for treating arthritis comprising HG1023575 polypeptide
US9051574B2 (en) * 2008-06-03 2015-06-09 University Of Maryland, Baltimore Non-hemolytic ClyA for excretion of proteins
CN102066945A (en) * 2008-06-19 2011-05-18 科技研究局 Modulators of STAT3 signalling
EP2324048A2 (en) * 2008-07-30 2011-05-25 Cosmix Therapeutics Llc Peptide therapeutics that bind vegf and methods of use thereof
EP2172477A1 (en) * 2008-10-06 2010-04-07 Atlas Antibodies AB Epitopes derived from SATB2 and uses thereof
US8156130B2 (en) 2008-10-17 2012-04-10 Embarq Holdings Company Llc System and method for collapsing search results
US8874564B2 (en) * 2008-10-17 2014-10-28 Centurylink Intellectual Property Llc System and method for communicating search results to one or more other parties
US8326829B2 (en) * 2008-10-17 2012-12-04 Centurylink Intellectual Property Llc System and method for displaying publication dates for search results
WO2010048125A2 (en) * 2008-10-22 2010-04-29 Trustees Of Dartmouth College Compositions and methods for inhibiting the interaction between cftr and cal
US9421239B2 (en) 2008-10-22 2016-08-23 Trustees Of Dartmouth College Therapy and kit for the prevention and treatment of cystic fibrosis
US9333235B2 (en) 2008-10-22 2016-05-10 Trustees Of Dartmouth College Combination therapy and kit for the prevention and treatment of cystic fibrosis
US8999919B2 (en) 2008-10-22 2015-04-07 Trustees Of Dartmouth College Compositions and methods for inhibiting the interaction between CFTR and CAL
EP2342355A4 (en) * 2008-10-29 2012-06-27 Beaumont Hospital William Methods of using biomarkers
CA2739705A1 (en) * 2008-10-30 2010-05-06 Yissum Research Development Company Of The Hebrew University Of Jerusale M Ltd. Efficient expression of truncated human rnaset2 in e. coli
US9855291B2 (en) 2008-11-03 2018-01-02 Adc Therapeutics Sa Anti-kidney associated antigen 1 (KAAG1) antibodies
US20110286924A1 (en) * 2008-12-09 2011-11-24 Alethia Biotherapeutics Inc Novel human endogenous retroviral erv3 variant and uses thereof in the diagnosing ovarian cancer
BRPI1006141B8 (en) * 2009-01-12 2021-05-25 Cytomx Therapeutics Llc modified antibody compositions, methods of making and using the same
CA2753294A1 (en) 2009-02-23 2010-08-26 Cytomx Therapeutics, Inc. Proproteins and methods of use thereof
CN102333543B (en) * 2009-02-24 2014-05-14 国立大学法人宫崎大学 Cell adhesion inhibitor and use thereof
EP2403864B1 (en) 2009-02-27 2015-08-12 Atyr Pharma, Inc. Polypeptide structural motifs associated with cell signaling activity
US8404242B2 (en) 2009-03-16 2013-03-26 Atyr Pharma, Inc. Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
PL2408913T3 (en) 2009-03-18 2017-07-31 Oncotherapy Science, Inc. Neil3 peptides and vaccines including the same
WO2010120509A2 (en) 2009-03-31 2010-10-21 Atyr Pharma, Inc. Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
WO2010118324A2 (en) 2009-04-09 2010-10-14 Nuclea Biotechnologies, LLC Antibodies against fatty acid synthase
CA2767570C (en) 2009-07-13 2018-05-01 Universite De Montreal Mutated sumo isoforms and uses thereof
JP2012533560A (en) 2009-07-15 2012-12-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Peptides that can control uptake in cells
WO2011031517A1 (en) 2009-08-27 2011-03-17 Nuclea Biotechnologies, LLC Method and assay for determining fas expression
KR101854820B1 (en) * 2009-09-25 2018-05-04 샤이어 오펀 테라피즈 게엠베하 Novel NPR-B Agonists
WO2011038066A2 (en) * 2009-09-25 2011-03-31 Alcon Research, Ltd. Novel npr-b agonists
WO2011040417A1 (en) * 2009-09-29 2011-04-07 学校法人福岡大学 Inositol-1,4,5-trisphosphate receptor binding protein, and transgenic non-human mammal containing same
DK2509625T3 (en) 2009-12-11 2015-04-27 Atyr Pharma Inc Histidyl tRNA synthetases to reduce inflammation
WO2011072266A2 (en) * 2009-12-11 2011-06-16 Atyr Pharma, Inc. Aminoacyl trna synthetases for modulating hematopoiesis
US8828395B2 (en) 2009-12-11 2014-09-09 Atyr Pharma, Inc. Antibodies that bind tyrosyl-tRNA synthetases
US9023802B2 (en) * 2009-12-14 2015-05-05 Immatics Biotechnologies Gmbh HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
TW201121995A (en) 2009-12-18 2011-07-01 Alcon Res Ltd Novel NPR-B agonists
PL2530091T3 (en) 2010-01-29 2018-08-31 Chugai Seiyaku Kabushiki Kaisha Anti-dll3 antibody
AU2011213609B2 (en) 2010-02-08 2016-11-03 Agensys, Inc. Antibody drug conjugates (ADC) that bind to 161P2F10B proteins
GB201002413D0 (en) 2010-02-12 2010-03-31 Procarta Biosystems Ltd Nucleic acid complexes
JP5655254B2 (en) * 2010-02-16 2015-01-21 国立大学法人京都工芸繊維大学 Polycarbonate and / or polymethyl methacrylate affinity peptide and use thereof
GB201005545D0 (en) 2010-04-01 2010-05-19 Procarta Biosystems Ltd Transcription factor decoys
JP6066900B2 (en) 2010-04-26 2017-01-25 エータイアー ファーマ， インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of cysteinyl tRNA synthetase
AU2011248614B2 (en) 2010-04-27 2017-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
CA2797259C (en) 2010-04-27 2020-09-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases
CA2797271C (en) 2010-04-28 2021-05-25 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
EP2563383B1 (en) 2010-04-29 2017-03-01 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
WO2011139854A2 (en) 2010-04-29 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
CN103108655B (en) 2010-05-03 2017-04-05 Atyr 医药公司 Treatment, diagnosis and the innovation of antibody compositions related to the protein fragments of seryl tRNA synzyme finds
US9034321B2 (en) 2010-05-03 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
CA2797277C (en) 2010-05-03 2021-02-23 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
CN103140233B (en) 2010-05-03 2017-04-05 Atyr 医药公司 Treatment, diagnosis and the discovery of antibody compositions related to the protein fragments of methionyl-tRNA synthetase
JP6008843B2 (en) 2010-05-04 2016-10-19 エータイアー ファーマ， インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of glutamyl-prolyl tRNA synthetase
CN102985103A (en) 2010-05-04 2013-03-20 Atyr医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
JP6396656B2 (en) 2010-05-14 2018-09-26 エータイアー ファーマ， インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of phenylalanyl βtRNA synthetase
US9034598B2 (en) 2010-05-17 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
WO2011146942A1 (en) * 2010-05-21 2011-11-24 The Translational Genomics Research Institute Methods and kits to analyze microrna by nucleic acid sequencing
CN103096913B (en) 2010-05-27 2017-07-18 Atyr 医药公司 Treatment, diagnosis and the innovation of antibody compositions related to the protein fragments of glutaminyl tRNA synzyme is found
RU2012157597A (en) 2010-05-31 2014-07-20 Лондон Хелс Сайенсис Сентр Рисерч Инк. RHAMM-BINDING PEPTIDES
AU2011261486B2 (en) 2010-06-01 2017-02-23 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-tRNA synthetases
CN103108649B (en) 2010-07-12 2016-10-12 Atyr医药公司 Treatment, diagnosis and the antibody compositions relevant to the protein fragments of Jo-1
US8969301B2 (en) 2010-07-12 2015-03-03 Atyr Pharma Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-tRNA synthetases
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
JP6116479B2 (en) 2010-07-12 2017-04-19 エータイアー ファーマ， インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of glycyl-tRNA synthetase
US10865445B2 (en) * 2010-08-18 2020-12-15 Fred Hutchinson Cancer Research Center Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule inhibiting the expression of DUX4-FL
WO2012027611A2 (en) 2010-08-25 2012-03-01 Atyr Pharma, Inc. INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES
CA2812644A1 (en) 2010-09-27 2012-04-05 Zestagen, S.A. Compositions and methods for treating neoplasia
TWI764324B (en) 2010-09-29 2022-05-11 美商艾澤西公司 Antibody drug conjugates (adc) that bind to 191p4d12 proteins
ES2645019T3 (en) 2010-10-06 2017-12-01 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic and antibody compositions related to tryptophanil-tRNA synthetases protein fragments
KR20130126671A (en) * 2010-12-14 2013-11-20 이매틱스 바이오테크놀로지스 게엠베하 Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
WO2012112842A2 (en) 2011-02-17 2012-08-23 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions and methods for treating poliovirus
US10370417B2 (en) 2011-03-01 2019-08-06 Rutgers, The State University Of New Jersey Methods for the diagnosis of cancer through detection of human endogenous retrovirus WL (HERV-WL) envelope expression
WO2012118974A2 (en) * 2011-03-01 2012-09-07 University Of Medicine And Dentistry Of New Jersey Detection of human endogenous retrovirus expression in cancer and normal cells
AU2012234754B2 (en) 2011-03-31 2016-09-29 Adc Therapeutics Sa Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
EP2511295A1 (en) * 2011-04-15 2012-10-17 Institut National De La Sante Et De La Recherche Medicale Compositions for preventing and/or treating an infection by an HIV-1 virus
US10654916B2 (en) 2011-04-21 2020-05-19 The Regents Of The University Of California, A California Corporation Compositions and methods for the treatment of neuromyelitis optica
CA2841249C (en) 2011-07-29 2023-09-26 Avelas Biosciences, Inc. Selective delivery molecules and methods of use
US9714419B2 (en) 2011-08-09 2017-07-25 Atyr Pharma, Inc. PEGylated tyrosyl-tRNA synthetase polypeptides
SG10201601840RA (en) * 2011-09-09 2016-04-28 Agency Science Tech & Res P53 activating peptides
US20130084582A1 (en) 2011-10-04 2013-04-04 Err-Cheng Chan Serological markers for detecting colorectal cancer and their application for inhibiting colorectal cancer cells
JP2014532408A (en) * 2011-10-26 2014-12-08 ニュークレア バイオテクノロジーズ インコーポレイテッドＮｕｃｌｅａ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅｓ，Ｉｎｃ． USP2a peptide and antibody
WO2013086216A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Improved aspartyl-trna synthetases
US9822353B2 (en) 2011-12-06 2017-11-21 Atyr Pharma, Inc. PEGylated aspartyl-tRNA synthetase polypeptides
AU2012368189B2 (en) 2011-12-29 2017-08-31 Atyr Pharma, Inc. Aspartyl-tRNA synthetase-Fc conjugates
JP6282597B2 (en) 2012-01-09 2018-02-21 アー・デー・ツェー・セラピューティクス・エス・アー How to treat breast cancer
WO2013123432A2 (en) 2012-02-16 2013-08-22 Atyr Pharma, Inc. Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
WO2013174404A1 (en) 2012-05-23 2013-11-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
EP3971571A3 (en) 2012-05-25 2022-06-08 The University of Vermont and State Agriculture College Compositions and methods for assaying platelet reactivity and treatment selection
EP2861622A4 (en) 2012-06-15 2016-06-01 Sinomab Bioscience Ltd Anti-cd22 anti-idiotypic antibodies and uses thereof
US9957557B2 (en) * 2012-08-13 2018-05-01 Life Genetics Lab, Llc Development of a highly sensitive quantification system for assessing DNA degradation and quality in forensic samples
KR20240033145A (en) 2012-11-13 2024-03-12 비온테크 에스이 Agents for treatment of claudin expressing cancer diseases
WO2014120837A2 (en) 2013-01-29 2014-08-07 The Regents Of The University Of California Pretargeted activatable cell penetrating peptide with intracellulary releaseable prodrug
CN105102484B (en) 2013-01-30 2020-03-10 艾维拉斯生物科学公司 Selective delivery molecules and methods of use
WO2014127785A1 (en) 2013-02-20 2014-08-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
KR20210108497A (en) 2013-02-26 2021-09-02 메모리얼 슬로안 케터링 캔서 센터 Compositions and methods for immunotherapy
US9409977B2 (en) 2013-03-12 2016-08-09 Decimmune Therapeutics, Inc. Humanized, anti-N2 antibodies
US10295547B2 (en) 2013-03-14 2019-05-21 University Of Florida Research Foundation, Incorporated Use and treatment of di-amino acid repeat-containing proteins associated with ALS
IL300508A (en) 2013-03-15 2023-04-01 Memorial Sloan Kettering Cancer Center Compositions and methods for immunotherapy
US9587235B2 (en) 2013-03-15 2017-03-07 Atyr Pharma, Inc. Histidyl-tRNA synthetase-Fc conjugates
WO2014146672A1 (en) 2013-03-18 2014-09-25 Ganymed Pharmaceuticals Ag Therapy involving antibodies against claudin 18.2 for treatment of cancer
EP2981607B1 (en) 2013-04-03 2020-08-19 Memorial Sloan Kettering Cancer Center Effective generation of tumor-targeted t-cells derived from pluripotent stem cells
EP2999710B1 (en) * 2013-05-20 2019-10-02 Nanyang Technological University Peptides binding to parallel-stranded g-quadruplexes
KR101841211B1 (en) * 2014-03-10 2018-03-22 한양대학교 산학협력단 Cell penetrating peptide and method for delivery of biologically active materials using it
WO2015176010A1 (en) 2014-05-15 2015-11-19 The United States Of America, As Represented By The Secretary, Departmentof Health & Human Services Treatment or prevention of an intestinal disease or disorder
WO2015188141A2 (en) 2014-06-06 2015-12-10 Memorial Sloan-Kettering Cancer Ceneter Mesothelin-targeted chimeric antigen receptors and uses thereof
US10653747B2 (en) 2014-07-31 2020-05-19 Uab Research Foundation ApoE mimetic peptides and higher potency to clear plasma cholesterol
WO2016022597A1 (en) * 2014-08-04 2016-02-11 Case Western Reserve University Targeting peptides and methods of use
US10925980B2 (en) 2014-08-04 2021-02-23 Case Western Reserve University Molecular probes and methods of use
CN107002046B (en) 2014-08-25 2021-05-11 经纬生物科技有限公司 Non-replicating transduction particles and transduction particle-based reporter systems
US10385380B2 (en) 2014-10-02 2019-08-20 The Regents Of The University Of California Personalized protease assay to measure protease activity in neoplasms
KR101693431B1 (en) 2014-11-18 2017-01-06 울산대학교 산학협력단 Targeting Peptides for Gastric Cancer and Medical Use Thereof
CA2969870A1 (en) 2014-12-05 2016-06-09 Memorial Sloan-Kettering Cancer Center Chimeric antigen receptors targeting b-cell maturation antigen and uses thereof
MY195115A (en) 2014-12-05 2023-01-10 Memorial Sloan Kettering Cancer Center Antibodies targeting g-protein coupled receptor and methods of use
SI3226897T1 (en) 2014-12-05 2021-08-31 Memorial Sloan Kettering Cancer Center Antibodies targeting b-cell maturation antigen and methods of use
JP7174522B2 (en) 2014-12-05 2022-11-17 メモリアル スローン ケタリング キャンサー センター Chimeric antigen receptor targeting Fc receptor-like 5 and uses thereof
HRP20211978T1 (en) 2014-12-05 2022-04-01 Memorial Sloan-Kettering Cancer Center Chimeric antigen receptors targeting g-protein coupled receptor and uses thereof
US10539572B2 (en) 2015-01-30 2020-01-21 Salk Institute For Biological Studies Compositions and methods for treating age-related diabetes and related disorders
US11497767B2 (en) 2015-02-18 2022-11-15 Enlivex Therapeutics R&D Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11318163B2 (en) 2015-02-18 2022-05-03 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11596652B2 (en) 2015-02-18 2023-03-07 Enlivex Therapeutics R&D Ltd Early apoptotic cells for use in treating sepsis
US11000548B2 (en) 2015-02-18 2021-05-11 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11304976B2 (en) 2015-02-18 2022-04-19 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11512289B2 (en) 2015-02-18 2022-11-29 Enlivex Therapeutics Rdo Ltd Combination immune therapy and cytokine control therapy for cancer treatment
EP3285877B1 (en) 2015-04-21 2022-10-19 Enlivex Therapeutics Rdo Ltd Therapeutic pooled blood apoptotic cell preparations and uses thereof
US10596259B2 (en) 2015-05-20 2020-03-24 The Regents Of The University Of California Tumor radiosensitization with monomethyl auristatin E (MMAE) and derivatives thereof
WO2016191263A1 (en) 2015-05-22 2016-12-01 Trustees Of Dartmouth College Therapy and kit for the prevention and treatment of cystic fibrosis
TW201702272A (en) 2015-05-22 2017-01-16 美國紀念斯隆 凱特琳癌症中心 T cell receptor-like antibodies specific for a PRAME peptide
WO2016196324A1 (en) 2015-05-29 2016-12-08 University Of Floridia Research Foundation, Inc. Methods for diagnosing huntington's disease
GB201511546D0 (en) 2015-07-01 2015-08-12 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
MA54884A (en) 2015-07-01 2022-01-12 Immatics Biotechnologies Gmbh NEUARTIGE PEPTIDE UND KOMBINATION AUS PEPTIDEN ZUR VERWENDUNG IN DER IMMUNTHERAPIE GEGEN OVARIALKARZINOM UND ANDERE KARZINOME
EP3328994A4 (en) 2015-07-31 2019-04-17 Memorial Sloan-Kettering Cancer Center Antigen-binding proteins targeting cd56 and uses thereof
CN115925806A (en) 2015-08-28 2023-04-07 伊玛提克斯生物技术有限公司 Novel peptides, peptide compositions and scaffolds for immunotherapy of various cancers
GB201515321D0 (en) 2015-08-28 2015-10-14 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
EP3341482B1 (en) * 2015-08-28 2022-07-06 CureVac AG Artificial nucleic acid molecules
WO2017040526A2 (en) * 2015-09-01 2017-03-09 Eisai R&D Management Co., Ltd. Splice variants associated with neomorphic sf3b1 mutants
CA2997551A1 (en) 2015-09-04 2017-03-09 Memorial Sloan Kettering Cancer Center Immune cell compositions and methods of use
EP3336098B1 (en) * 2015-09-10 2021-08-11 IUCF-HYU (Industry-University Cooperation Foundation Hanyang University) Skin permeable peptide and method for using same
AU2016362402A1 (en) 2015-12-04 2018-06-28 Eureka Therapeutics, Inc. Antibodies targeting Fc receptor-like 5 and methods of use
WO2017100428A1 (en) 2015-12-09 2017-06-15 Memorial Sloan Kettering Cancer Center Immune cell compositions and methods of using same
JP7022067B2 (en) 2016-01-14 2022-02-17 メモリアル スローン ケタリング キャンサー センター T-cell receptor-like antibody specific for FOXP3-derived peptide
CA3014885A1 (en) 2016-02-18 2017-08-24 Enlivex Therapeutics Ltd. Combination immune therapy and cytokine control therapy for cancer treatment
GB201604490D0 (en) 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Peptides combination of peptides for use in immunotherapy against cancers
US10940161B2 (en) 2016-04-04 2021-03-09 University Of Florida Research Foundation, Incorporated Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation
PT3443075T (en) 2016-04-15 2022-12-16 Memorial Sloan Kettering Cancer Center Transgenic t cell and chimeric antigen receptor t cell compositions and related methods
WO2017218949A2 (en) * 2016-06-17 2017-12-21 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
US20180052169A1 (en) * 2016-08-22 2018-02-22 The Board Of Regents Of The University Of Texas System Tsp1 as a marker for cancer
CA3034691A1 (en) 2016-08-30 2018-03-08 Memorial Sloan Kettering Cancer Center Immune cell compositions and methods of use for treating viral and other infections
AU2017342555A1 (en) 2016-10-14 2019-05-30 Children's Medical Center Corporation Compositions and methods for treating diseases and disorders of the central nervous system
CA3042706A1 (en) 2016-11-09 2018-05-17 Intrexon Corporation Frataxin expression constructs
JP2020502056A (en) * 2016-11-13 2020-01-23 イマジン ファーマ Compositions and methods for treating diabetes, hypertension and hypercholesterolemia
GB201621737D0 (en) * 2016-12-20 2017-02-01 Aberystwyth Univ Compositions and methods of treatment
US11566060B2 (en) 2017-01-05 2023-01-31 Kahr Medical Ltd. PD1-CD70 fusion protein and methods of use thereof
US11299530B2 (en) 2017-01-05 2022-04-12 Kahr Medical Ltd. SIRP alpha-CD70 fusion protein and methods of use thereof
HRP20220230T1 (en) 2017-01-05 2022-04-29 Kahr Medical Ltd. A sirp1 alpha-41bbl fusion protein and methods of use thereof
DK3565579T3 (en) 2017-01-05 2023-09-04 Kahr Medical Ltd PD1-41BBL FUSION PROTEIN AND METHODS OF USING THEREOF
AU2018210853B2 (en) 2017-01-17 2023-09-28 Children's Medical Center Corporation Compositions and methods for treating lysosomal storage diseases and disorders
EP3576781B9 (en) 2017-01-18 2024-03-06 Icahn School of Medicine at Mount Sinai Neoantigens and uses thereof for treating cancer
US11260101B2 (en) * 2017-02-28 2022-03-01 Jinan University Repair peptide for use in promoting post-traumatic tissue repair and regeneration, and application thereof
AU2018231190B2 (en) 2017-03-08 2023-05-25 Memorial Sloan Kettering Cancer Center Immune cell compositions and methods of use
ES2955852T3 (en) 2017-04-03 2023-12-07 Hoffmann La Roche STEAP-1 binding antibodies
JP2020516674A (en) 2017-04-17 2020-06-11 ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． Regulation of RAN protein translation by the PKR and eIF2A-P pathways
EP3612215A4 (en) 2017-04-20 2021-05-26 aTyr Pharma, Inc. Compositions and methods for treating lung inflammation
SG11201910101SA (en) 2017-05-08 2019-11-28 Gritstone Oncology Inc Alphavirus neoantigen vectors
CA3063464A1 (en) * 2017-05-19 2018-11-22 Encoded Therapeutics, Inc. High activity regulatory elements
WO2019067587A1 (en) 2017-09-26 2019-04-04 University Of Florida Research Foundation, Incorporated Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders
WO2019067592A1 (en) 2017-09-27 2019-04-04 University Of Georgia Research Foundation Treatment and detection of infection and disease associated with different fungal pathogens
AU2018367452A1 (en) 2017-11-14 2020-06-11 Memorial Sloan-Kettering Cancer Center IL-36 secreting immunoresponsive cells and uses thereof
US11008602B2 (en) 2017-12-20 2021-05-18 Roche Molecular Systems, Inc. Non-replicative transduction particles and transduction particle-based reporter systems
TWI817974B (en) 2017-12-28 2023-10-11 日商中外製藥股份有限公司 Cytotoxicity-inducing therapeutic agent
JP7416695B2 (en) 2017-12-29 2024-01-17 メモリアル スローン－ケタリング キャンサー センター Enhanced chimeric antigen receptors and their uses
BR112020013679A2 (en) 2018-01-04 2020-12-01 Iconic Therapeutics, Inc. antitecid factor antibodies, antibody-drug conjugates and related methods
CA3081125A1 (en) 2018-02-01 2019-08-08 Innovent Biologics (Suzhou) Co., Ltd. Fully humanized anti-b cell maturation antigen (bcma) single-chain antibody and use thereof
KR20200120673A (en) 2018-02-11 2020-10-21 메모리얼 슬로안 케터링 캔서 센터 Non-HLA restricted T cell receptor and uses thereof
CA3091143A1 (en) 2018-02-15 2019-08-22 Memorial Sloan-Kettering Cancer Center Foxp3 targeting agent compositions and methods of use for adoptive cell therapy
EP3740247A4 (en) 2018-03-02 2022-06-08 Dicerna Pharmaceuticals, Inc. Compositions and methods for inhibiting gys2 expression
SG11202013167UA (en) 2018-07-11 2021-01-28 Kahr Medical Ltd SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOF
EP3880714A4 (en) 2018-11-16 2022-07-20 Memorial Sloan Kettering Cancer Center Antibodies to mucin-16 and methods of use thereof
EP3947471A4 (en) 2019-03-27 2023-03-15 The Trustees of The University of Pennsylvania Tn-muc1 chimeric antigen receptor (car) t cell therapy
CN110256574B (en) * 2019-05-21 2020-12-04 山东大学 Fusion polypeptide and application thereof in preparing medicament for resisting depression and neurodegenerative diseases
KR20220016137A (en) 2019-05-30 2022-02-08 그릿스톤 바이오, 인코포레이티드 modified adenovirus
EP4041745A4 (en) * 2019-10-08 2024-02-07 Univ North Carolina State Immunoglobulin purification peptides and their use
BR112022007952A2 (en) 2019-10-28 2022-10-04 Noile Immune Biotech Inc DRUG TO TREAT CANCER, COMBINATION DRUG, DRUG COMPOSITION, IMMUNE RESPONSIVE CELL, NUCLEIC ACID DELIVERY VEHICLE AND PRODUCT
CA3160468A1 (en) * 2019-11-05 2021-05-14 Board Of Regents, The University Of Texas System Hla restricted hormad1 t cell receptors and uses thereof
WO2021158818A1 (en) * 2020-02-05 2021-08-12 Synthetic Genomics, Inc. Regulatory sequences for expression of transgenes
CA3172447A1 (en) 2020-03-27 2021-09-30 Erik Hans MANTING In vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
CN115916963A (en) 2020-03-27 2023-04-04 门德斯有限公司 Ex vivo use of modified cells of leukemia origin for enhancing the efficacy of adoptive cell therapy
CN115397866A (en) 2020-03-31 2022-11-25 中外制药株式会社 DLL 3-targeted multispecific antigen-binding molecules and uses thereof
AU2021300112A1 (en) 2020-06-29 2023-02-16 Cell Medica, Inc. Methods and compositions for the reduction of chimeric antigen receptor tonic signaling
KR20230046313A (en) 2020-08-06 2023-04-05 그릿스톤 바이오, 인코포레이티드 Multi-epitope vaccine cassette
WO2022035793A1 (en) 2020-08-10 2022-02-17 Precision Biosciences, Inc. Antibodies and fragments specific for b-cell maturation antigen and uses thereof
EP4222267A1 (en) 2020-09-30 2023-08-09 Vor Biopharma Inc. Chimeric antigen receptor expression systems
JP2023547520A (en) 2020-11-05 2023-11-10 メンドゥス・ベスローテン・フェンノートシャップ Use of tumor-independent antigens in immunotherapy
WO2022104090A1 (en) 2020-11-13 2022-05-19 Vor Biopharma Inc. Methods and compositions relating to genetically engineered cells expressing chimeric antigen receptors
WO2022189626A2 (en) 2021-03-11 2022-09-15 Mnemo Therapeutics Tumor neoantigenic peptides
JP2024511941A (en) * 2021-03-11 2024-03-18 テンザ、インク． Synthetic signal peptides to direct secretion of heterologous proteins in yeast
EP4304635A1 (en) 2021-03-11 2024-01-17 Mnemo Therapeutics Tumor neoantigenic peptides and uses thereof
KR20240006721A (en) 2021-03-11 2024-01-15 엥스띠뛰 퀴리 Membrane-transforming neoantigen peptide
WO2022221420A2 (en) * 2021-04-13 2022-10-20 Capsida, Inc. Selected aav compositions having preferred brain enrichment
JP2024514933A (en) 2021-04-23 2024-04-03 ベイラー カレッジ オブ メディスン CAR NKT expressing artificial microRNA-embedded SHRNA for down-regulation of MHC class I and II expression
WO2022235832A1 (en) 2021-05-06 2022-11-10 Ludwig Institute For Cancer Research Ltd Compositions and methods for immunotherapy
WO2022238386A1 (en) 2021-05-10 2022-11-17 Institut Curie Methods for the treatment of cancer, inflammatory diseases and autoimmune diseases
EP4346912A1 (en) 2021-05-25 2024-04-10 Institut Curie Myeloid cells overexpressing bcl2
WO2023288203A2 (en) 2021-07-12 2023-01-19 Ludwig Institute For Cancer Research Ltd T cell receptors specific for tumor-associated antigens and methods of use thereof
WO2023022788A1 (en) * 2021-08-18 2023-02-23 The Regents Of The University Of California Methods and compositions for determining risk of autism spectrum disorders
WO2023064872A1 (en) 2021-10-14 2023-04-20 Precision Biosciences, Inc. Combinations of anti-bcma car t cells and gamma secretase inhibitors
WO2023192626A1 (en) * 2022-04-01 2023-10-05 The Regents Of The University Of California Methods and compositions for treating gliomas
US20240002800A1 (en) 2022-05-16 2024-01-04 Mendus B.V. Use of leukemia-derived cells for enhancing natural killer (nk) cell therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287801B1 (en) * 1996-07-22 2001-09-11 Smithkline Beecham Corporation Nucleic acids encoding the G-protein coupled receptor HNFDS78
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
US20030235883A1 (en) * 2000-03-31 2003-12-25 Tang Y. Tom Novel nucleic acids and polypeptides
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides

Also Published As

Publication number Publication date
US6610536B2 (en) 2003-08-26
US20020146757A1 (en) 2002-10-10
US20030096279A1 (en) 2003-05-22
US20020061567A1 (en) 2002-05-23
WO2001075067A2 (en) 2001-10-11
US6436703B1 (en) 2002-08-20
WO2001075067A9 (en) 2002-10-31
WO2001075067A3 (en) 2002-04-04
AU2001249251A1 (en) 2001-10-15
US20030092112A1 (en) 2003-05-15
US20030087370A1 (en) 2003-05-08
US20050196754A1 (en) 2005-09-08

Similar Documents

Publication Publication Date Title
WO2001075067A3 (en) Novel nucleic acids and polypeptides
WO2001057188A3 (en) Novel nucleic acids and polypeptides
WO2001057190A3 (en) Novel nucleic acids and polypeptides
WO2002022660A3 (en) Novel nucleic acids and polypeptides
WO2001066689A3 (en) Novel nucleic acids and polypeptides
WO2002031111A3 (en) Novel nucleic acids and polypeptides
WO2001088088A3 (en) Novel nucleic acids and polypeptides
WO2002059260A3 (en) Nucleic acids and polypeptides
WO2003054152A3 (en) Novel nucleic acids and polypeptides
WO2003025148A3 (en) Novel nucleic acids and polypeptides
WO2002070539A3 (en) Novel nucleic acids and polypeptides
WO2003023013A3 (en) Novel nucleic acids and polypeptides
WO2002081731A3 (en) Novel nucleic acids and polypeptides
WO2001053312A8 (en) Novel nucleic acids and polypeptides
WO2001053455A3 (en) Novel nucleic acids and polypeptides
WO2004009834A3 (en) Novel nucleic acids and secreted polypeptides
WO2003029271A3 (en) Novel nucleic acids and polypeptides
WO2004080148A3 (en) Novel nucleic acids and polypeptides
WO2002018424A3 (en) Nucleic acids and polypeptides
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2001079449A3 (en) Novel nucleic acids and polypeptides
WO2001002571A3 (en) An interleukin-1 receptor antagonist and uses thereof
WO2003080795A3 (en) Novel nucleic acids and secreted polypeptides
WO2001075068A3 (en) Secreted proteins and polynucleotides encoding them
WO2002044340A3 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 99-3870, DESCRIPTION, ADDED; PAGES 99-102, CLAIMS, RENUMBERED AS 3871-3874

122 Ep: pct application non-entry in european phase
WWE Wipo information: entry into national phase

Ref document number: 10450763

Country of ref document: US

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 41/2001 UNDER "PUBLISHED" ADD "SEQUENCE LISTING PART OF DESCRIPTION PUBLISHED SEPARATELY IN ELECTRONIC FORM AND AVAILABLE UPON REQUEST FROM THE INTERNATIONAL BUREAU"

NENP Non-entry into the national phase

Ref country code: JP